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Abstract
Background and aims: Ileo-colonoscopy is the procedure of choice for chronic nonbloody diarrhea (CNBD) of unknown origin.
Histological evaluation at different colonic sites is mandatory to assess the presence of microscopic colitis. However, the value of
routine ileal biopsy on normal-appearing mucosa as assessed by means of standard-resolution white-light ileoscopy is contro-
versial given its reported low diagnostic yield. Hence, we have assessed for the first time the accuracy of retrograde ileoscopy using
high-definition and dyeless chromoendoscopy (HDþ DLC), thereby calculating the impact and cost of routine ileal biopsy in CNBD.
Methods: Patients with CNBD of unknown origin were prospectively enrolled for ileo-colonoscopy with HDþ DLC at five
referral centers. Multiple biopsies were systematically performed on each colorectal segment and in the terminal ileum for
histopathological analysis.
Results: Between 2014 and 2017, 546 consecutive patients were recruited. Retrograde ileoscopy success rate was 97.6%. A total
of 492 patients (mean age: 53 18 years) fulfilled all the inclusion criteria: Following endoscopic and histopathological work-
up, 7% had lymphoid nodular hyperplasia and 3% had isolated ileitis. Compared to the histopathology as the gold standard,
retrograde ileoscopy with HDþDLC showed 93% sensitivity, 98% specificity and 99.8% negative predictive value. In patients
with normal ileo-colonoscopy, ileum histology had no diagnostic gain and resulted in a cost of US $26.5 per patient.
Conclusions: Retrograde ileoscopy with HD þ DLC predicts the presence of ileitis in CNBD with excellent performance. The
histopathological evaluation of the terminal ileum is the gold standard for the diagnostic assessment of visible lesions but
has no added diagnostic value in CNBD patients with negative ileo-colonoscopy inspection using modern endoscopic
imaging techniques.
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Key summary
1. In the work-up for chronic nonbloody diarrhea (CNBD) of unknown origin, ileo-colonoscopy with
histological evaluation at different colonic sites is mandatory.
– Histopathological evaluation of the terminal ileum is the gold standard for diagnostic assessment of
visible lesions.
– By contrast, the value of routine ileal biopsy on normal-appearing mucosa is controversial.
2. The histopathological evaluation of the terminal ileum has no added diagnostic value in CNBD patients
with negative ileo-colonoscopy inspection using modern endoscopic imaging techniques.
– Retrograde ileoscopy with high-definition and dyeless chromoendoscopy predicts the presence of ileitis
in CNBD with excellent performance.
Introduction
Retrograde ileoscopy with biopsy is widely recognized
as a key element for the diagnostic evaluation of
chronic diarrhea, especially in patients suspected of
having inflammatory illness.1–3 The differential diagno-
sis for abnormal endoscopic and histological findings in
the terminal ileum includes Crohn disease, drug-
induced enteropathy, carcinoid, tuberculosis, yersinio-
sis, lymphoma and adenocarcinoma.1,3–6 Histology
may be of greatest value when an abnormal terminal
ileum is identified endoscopically or via an imaging
study.3,6,7 However, the value of ileal biopsy on
normal-appearing mucosa is controversial in the rou-
tine assessment of patients suffering from chronic diar-
rhea, with significant findings ranging from 0% to 4.2%
of retrograde ileoscopy performed with standard-reso-
lution white-light endoscopy.1,5,7–10
More recently, high-definition (HD) endoscopy sys-
tems, integrated with optical or digital virtual chro-
moendoscopy, have become widely available in daily
clinical practice.10–12 These modern endoscopic imaging
techniques improve the detection of subtle lesions by
providing high-quality mucosal-surface and vascular-
pattern imaging, thereby enabling more precise and
on-demand targeted biopsy.13
Accordingly, the aim of this prospective, multicenter
trial was first to assess the diagnostic accuracy of retro-
grade ileoscopy with HD and dyeless chromoendo-
scopy in patients with chronic nonbloody diarrhea
(CNBD) of unknown origin using histopathology as
the gold standard, and second to determine the diag-
nostic yield and cost of routine biopsies of the terminal
ileum for histopathological assessment beyond normal-
appearing mucosa in CNBD.
Methods
Patients
A prospective cohort study was performed across five
tertiary referral centers in northern Italy (Como, Forlı`,
Monza, Padua and San Donato Milanese). Adults
referred for colonoscopy were consecutively enrolled
according to the following inclusion criteria:
. CNBD of unknown origin, defined by more than
three loose or liquid nonbloody stools per day, for
a minimum of four consecutive weeks.1
. Absence of active disorders that correspond to one of
the following: celiac disease, lactose/fructose intoler-
ance, known inflammatory bowel disease (IBD).
. No severe uncontrolled coagulopathy, pregnancy or
breastfeeding.
Patients with one of the following criteria were
excluded from the study analysis:
. Boston bowel preparation scale  2 in any segment.
. History of large-bowel or small-bowel surgery.
. Incomplete ileo-colonoscopy with biopsy or incom-
plete image documentation.
Endoscopic procedure
All colonoscopies were performed under conscious or
deep sedation by experienced endoscopists, using HD
and virtual chromoendoscopy systems including either
optical (Narrow Band Imaging, NBI, Olympus, Tokyo,
Japan) or digital technologies (i-SCAN, Pentax, Tokyo,
Japan; Storz Professional Image Enhancement
Systems, SPIES, Karl Storz, Tuttlingen, Germany)
according to local availability. Endoscopic incidents
and adverse events were prospectively recorded using
the American Society for Gastrointestinal Endoscopy
(ASGE) lexicon.14
As per protocol, a clear, detailed description of every
segment was performed, including at least two images
demonstrating a stable ileoscopy visualization for at
least 30 seconds by means both of HD white-light
endoscopy and virtual chromoendoscopy. Afterward,
no fewer than two large biopsies (i.e. 9-mm diameter
of opened jaws, e.g. Radial Jaw 4 Biopsy Forceps,
Boston Scientific, Natick, MA, USA, or similar) of a
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grossly normal mucosa were randomly performed in
the terminal ileum (usually 5–15 cm proximal to the
ileocecal valve), right colon, transverse colon, left
colon and rectum. Additional targeted samples were
systematically collected from any visible endoscopic
lesion. Biopsy specimens were immediately fixed in buf-
fered formalin and stored in separate vials to map any
endoscopic and microscopic finding in different ileoco-
lonic segments.
Histopathological analysis
Ileocolorectal biopsy specimens underwent identical
sectioning and hematoxylin and eosin staining followed
by specific additional staining when needed (e.g.
immunohistochemistry, trichrome). Histopathological
analysis was performed by two dedicated subspeci-
alty-trained gastrointestinal pathologists at each ter-
tiary referral center involved in the present study. The
histopathological diagnostic definition of microscopic
colitis,15 IBD,16 eosinophilic17 or drug-induced entero-
colitis18 followed the established standard of care out-
lined in the literature. The terms nonspecific colitis or
ileitis were adopted for moderate-to-severe microscopic
inflammatory tissue changes without a definitive diag-
nosis (i.e. increased lamina propria cellularity without
cryptitis, apoptotic bodies or features of ‘‘incomplete
microscopic colitis’’).3,15,16,18
Ethics
All patient records (inclusion/exclusion criteria, endo-
scopic and histopathological findings) were anonymized
and prospectively collected in a structured database. Each
center received formal approval from the local ethics
committee before study initiation. The patients gave
their informed written informed consent prior to ileo-
colonoscopy for the present trial. This study was carried
out in accordance with the Declaration of Helsinki
adopted in 1964 incorporating all later amendments.
Statistical analysis
The descriptive statistics were presented as meansSD
for continuous variables and percentages for categor-
ical variables. We estimated diagnostic variables such
as sensibility, specificity, likelihood ratios and relative
confidence intervals (which were calculated using the
95% confidence level (CI)). Statistical analysis was car-
ried out by R software.
Cost analysis
For the estimation of the terminal ileum histopatho-
logical assessment cost, we searched the database of
one Italian referral center (Foundation IRCCS Ca’
Granda Ospedale Maggiore Policlinico, University of
Milan) and one United States (US) referral center
(Cleveland Digestive Diseases Research Core Center,
Cleveland, OH, Case Western Reserve University)
asking about the following costs: (a) disposable con-
tainer preloaded with buffered formalin; (b) standard
slide preparation (specimen embedding, sectioning,
hematoxylin and eosin staining); (c) standard slide
pathology review; and (d) specimen sectioning for two
additional staining and additional pathological review
for special situations (e.g. difficult diagnostic definition
of terminal ileum entities in patients with CNBD
requiring specific immunohistochemistry). The cost of
each terminal ileum histopathological assessment was
then calculated by adding the fixed costs (a), (b) and (c)
to the cost (d) multiplied by its variable frequency
within the study population.
Results
A total of 546 patients with CNBD met the inclusion
criteria and were consecutively enrolled between 2014
and 2017 at participating centers.
The ileal intubation rate was 97.6%. Based on the
exclusion criteria, 492 patients (209 men; mean age:
53 18 years) were ultimately included in the statistical
analysis (Figure 1). No endoscopic incidents or adverse
events related to ileo-colonoscopy with biopsy occurred.
By combining the results achieved during the endo-
scopic and histopathological work-up, 79% of our
study population had a fully negative diagnostic
work-up, while 21% received a final diagnosis consist-
ent with the history of CNBD (Supplementary Figure
1). The most prevalent entity was microscopic colitis,
with 43 new cases detected (8.7%), 28 collagenous and
15 lymphocytic colitis. Among them, the endoscopic
inspection with HD plus virtual chromoendoscopy
showed the presence of moderate (erosions, cat
scratches) to mild (hyperemia, edema) colorectal
inflammatory lesions in seven out of 43 cases (16%).
In the remaining 36/43 patients, histopathology based
on multiple random colon and rectum biopsies led to
the definite diagnosis of microscopic colitis following a
fully negative ileo-colonoscopy with HD plus virtual
chromoendoscopy.
Retrograde ileoscopy findings and accuracy
Retrograde ileoscopy with HD and virtual chromoen-
doscopy revealed the features of lymphoid nodular
hyperplasia in 34 patients (7%). Histopathological ana-
lysis based on terminal ileum biopsy samples confirmed
the endoscopic appearance of lymphoid nodular hyper-
plasia in all the cases (sensitivity/specificity 100%).
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Apart from lymphoid nodular hyperplasia, retro-
grade ileoscopy identified inflammatory lesions in 22
patients (4%) (Figure 2); 15 of whom (3%) had a nega-
tive endoscopic inspection throughout their colon and
rectum (i.e. isolated ileitis; Supplementary Figure 1).
Histopathology confirmed the presence of relevant
inflammatory lesions in the terminal ileum samples
of 14 patients with endoscopic ileitis and in one
patient affected by severe Crohn disease located in
the right colon showing severe cellular infiltrate
beyond a normal-appearing terminal ileum (Table 1,
Supplementary Figure 2). Based on the histopatho-
logical gold standard, the accuracy of retrograde ileo-
scopy with HD plus virtual chromoendoscopy imaging
was 98.2%. The corresponding performance measures
of retrograde ileoscopy are shown in Table 2. Notably,
the histopathological assessment based on multiple
random biopsies of the terminal ileum had no clinical
impact on the CNBD patients with a fully negative HD
plus virtual chromoendoscopy ileo-colonoscopy inspec-
tion (i.e. sensitivity/specificity 100%).
The use of digital (i-SCAN or Flexible Spectral-
Imaging Color Enhancement (FICE)) and optical (NBI
or SPIES) chromoendoscopy was equally distributed in
our study cohorts (46.1% and 53.9%, respectively).
However, the rate of patients with confirmed terminal
ileitis was much greater in the digital chromoendoscopy
group (12/15). Both optical and digital chromoendo-
scopy HD ileoscopy showed excellent accuracy levels
(99.2%, 95% CI¼ 97.3%–99.9%; 96.9%, 95%
CI¼ 93.8%–98.8%, respectively) and a perfect negative
predictive value (100%, 95% CI¼ 98%–100%, for
both) using histopathology as the gold standard. The
best sensitivity level was found using digital chromoen-
doscopy techniques (sensitivity: 100%, 95% CI¼ 74%–
100%; specificity: 97%, 95% CI¼ 93%–99%), while
the best specificity was with optical chromoendoscopy
(sensitivity: 67%, 95% CI 90%–99%; specificity:
100%, 95% CI¼ 99%–100%). Whether this figure
reflects different features of optical and digital chro-
moendoscopy rather than center- or operator-driven
factors cannot be definitively ascertained according to
the observational design of this study and to the
smaller prevalence of ileitis in the optical chromoendo-
scopy groups.
Costs related to the terminal ileum
histopathological assessment
The estimated costs for standard slide preparation
(including specimen embedding, sectioning, hematoxy-
lin and eosin staining and pathology review) were
E15.25 and $21.55, respectively, at the Italian and US
high-volume referral centers. Specific situations requir-
ing additional sectioning of terminal ileum specimens
for additional staining with immunohistochemistry and
additional pathology review occurred every 10 CNBD
patients (Table 3). All in all, the Italian and US costs
Consecutive ileo-colonoscopies
Inclusion criteria:
• CNBD of unknown origin
•  No active celiac disease, distiroydism, severe immunodeficiency,
    intestinal ischemia, entero-colitic infectious
• No severe uncontrolled coagulopathy, pregnancy or breast-feeding
Excluded (n =54)
• BBPS < 2 in one segment (n =23)
• History of small-bowel surgery (n =2)
• Incomplete ileo-colonoscopy with biopsy or incomplete image
 documentation (n = 29)
Assessed for elegibility (n = 546)
High-definition ileoscoopy plus
dye-less chromoendoscopy (n = 492)
Biopsy protocol and histopathology
Prospective and anonymous data
collection into structured database
Data analysis
Figure 1. Study flowchart.
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directly related to the additional histopathological
assessment of the terminal ileum in each patient per-
forming colonoscopy with multiple colorectal biopsies
were E18.20 and $26.50, respectively.
Figure 2. (a and b) High-definition plus i-SCAN mode 1 and i-SCAN mode 3 imaging of a normal-appearing terminal ileum as confirmed
by histopathology on multiple random biopsy samples. (c and d) High-definition plus i-SCAN mode 1 and i-SCAN mode 2 imaging of small
superficial ulcers diagnosed as Crohn disease ileitis by histopathology on targeted biopsies. (e and f) High-definition plus i-SCAN mode 1
and i-SCAN mode 2 imaging of mild hyperemia and edema of the terminal ileum in nonsteroidal anti-inflammatory drug-induced ileitis
according to histopathology on targeted biopsies and clinical history.
Table 2. Statistical measures of the performance of retrograde
ileoscopy with high-definition plus virtual chromoendoscopy using
histopathology as the gold standard.
Test Value
Sensitivity 0.933 (0.660–0.996)
Specificity 0.983 (0.966–0.992)
Positive predictive value 0.636 (0.408–0.820)
Negative predictive value 0.998 (0.986–1)
Positive likelihood ratio 55.6 (27.6–112.1)
Negative likelihood ratio 0.068 (0.010–0.450)
Table 1. Detection of ileitis by means of ileo-colonoscopy with
high-definition plus virtual chromoendoscopy and histopatho-
logical assessment.
Histopathology þ Histopathology – Total
Ileoscopy þ 14 8 22
Ileoscopy – 1 469 470
Total 15 477 492
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Discussion
CNBD of unknown origin is one of the major indica-
tions for gastrointestinal endoscopy and accounts for
approximately 4%–7% of all the colonoscopies per-
formed in Western countries.19–21 Multiple endoscopic
biopsies and histopathological assessment represent an
essential step to ascertain the diagnostic definition of
macroscopic lesions and exclude the underlying pres-
ence of microscopic colitis.9,22 The diagnostic yield of
colonoscopy with biopsies in CNBD patients ranges
from 7% to 32%, with microscopic colitis and IBD
being most common.1–5,8–10,16–18 The present multicen-
ter study, conducted in a real-life setting, identified a
relevant number of patients suffering from microscopic
colitis (9%), IBD (6%), adenocarcinoma (1%) and
other inflammatory conditions corresponding to the
clinical history of CNBD (Supplementary Figure 1).
Our study has confirmed that retrograde ileoscopy
can be safely accomplished in up to 98% of colonosco-
pies, resulting in the detection of visible ileitis in 4% of
patients suffering from CNBD. Interestingly, a definite
diagnosis of inflammatory illness with isolated involve-
ment of the terminal ileum was achieved in 3% of all
the CNBD patients, who would have otherwise been
dismissed with the wrong putative diagnosis of irritable
bowel syndrome (IBS) (Supplementary Figure 1).
However, retrograde ileoscopy is not yet accepted
among the standard quality indicators for colonos-
copy,23–25 and it is often regarded as a matter for refer-
ral to IBD endoscopy units. Several retrospective
studies in real-life clinical settings have clearly shown
that retrograde ileoscopy is performed in only 45% to
87%3,8,26–28 of patients with chronic diarrhea. By con-
trast, prospective studies aimed at performing ileal
intubation in all cases have shown higher success
rates (90%–95.5%),3,17 thereby suggesting ample
room for improvement in everyday clinical practice.
The value of random biopsies routinely performed
on the terminal ileum of patients with CNBD and
negative ileo-colonoscopy dates back to the era of
low-resolution endoscopic imaging, when subtle muco-
sal lesions could have been overlooked. Within this
setting, the histopathological assessment of normal-
appearing mucosa of the terminal ileum was found
positive for relevant small-bowel pathologies, including
isolated Crohn disease and lymphoma, in up to 4% of
patients with chronic diarrhea of unknown
origin.5,7–9,29 In 2010, the Standards-of-Practice
Committee of the ASGE stated that the yield of
biopsy of an endoscopically normal-appearing terminal
ileum is likely to be low and highlighted the lack of
evidence to determine whether this practice should be
routinely performed on patients with chronic unex-
plained diarrhea.1 More recently, anecdotal cases of
microscopic ileitis have also been described in
diverted-enteric-segment and collagenous colitis.30
However, the clinical relevance of microscopic ileitis
is still unknown in non-IBD patients.
Hence, we assessed for the first time the accuracy of
retrograde ileoscopy with HD and virtual chromoendo-
scopy using histopathology as the gold standard. Our
results have clearly showed that ileoscopy with
advanced imaging can predict the presence of micro-
scopic ileitis in CNBD patients with excellent accuracy.
Consistently, routine endoscopic biopsy of the terminal
ileum had no diagnostic yield in CNBD patients with
fully negative ileo-colonoscopy using HD imaging and
virtual chromoendoscopy, and it should be avoided
except for specific indications, thereby resulting in
$26.50 saved per patient (Table 3).
By contrast, histopathology based on multiple
random biopsies of the colon and rectum is crucial
for the diagnosis of microscopic colitis regardless of
the presence of visible inflammatory lesions.
Consistent with the literature,19,22,31 most patients diag-
nosed with microscopic colitis (84%) in the present
study had a fully negative ileo-colonoscopy, even des-
pite the use of HD and virtual chromoendoscopic
imaging.
Table 3. Cost analysis of additional histopathological assessment of the terminal ileum for every Italian and United States (US) patient
undergoing colonoscopy with multiple colorectal biopsies for chronic nonbloody diarrhea.
Additional procedure Workflow
Italian cost
in Euros (E)
US cost in
dollars ($)
Endoscopic sampling Terminal ileum biopsies (two to four bites) placed in a separate
disposable container preloaded with buffered formalin
0.25 0.25
Standard slide preparation Specimen embedding, sectioning, hematoxylin and eosin staining 10.00 12.00
Pathology review Reading, analysis and report drafting 5.00 9.30
Special situationsa Specimens sectioned for two additional immunohistochemistry
staining and pathology review
30.00 50.00
Total cost 18.25 26.55
aSpecial situations occurred every 10 patients on average.
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The application of rigorous inclusion and exclusion
criteria for patient enrollment together with the pro-
spective nature of this multicenter cohort study repre-
sent an optimal methodological background to support
our results. However, some points regarding this study
should be addressed. First, two dedicated subspecialty-
trained gastrointestinal pathologists were systematic-
ally involved in all histopathological analyses at each
tertiary referral center but no external revision by
blinded pathologists was performed for research pur-
poses. Second, no case of adenocarcinoma or lymph-
oma of the terminal ileum was detected, resulting in no
opportunity to assess the performance of HD plus vir-
tual chromoendoscopy in oncologic disorders. However,
these conditions are quite uncommon in patients with
CNBD,32 and are usually associated with clear endo-
scopic abnormalities given their erosive nature. Third,
as far as the study protocol was concerned, our results
could not assess the additional impact of virtual chro-
moendoscopy beyond HD white-light imaging. In other
settings, the routine use of advanced endoscopic imaging
was found to increase the detection and the operators’
confidence in characterizing and delineating subtle
inflammatory lesions, such as isolated erosions, hyper-
emia and/or edema.10–13 Finally, no long-term follow-up
was designed to evaluate whether those patients with a
negative endoscopic and histological work-up achieved
symptom remission or eventually had any diagnosis of
other disorders consistent with CNBD. In these cases,
we hypothesized the functional origin of the diarrhea
with the putative diagnosis of IBS or colonic diverticular
disease.
In conclusion, this large, prospective, multicenter
study has clearly shown that retrograde ileoscopy
with HD imaging and virtual chromoendoscopy can
predict the presence of ileitis in patients with CNBD
with excellent accuracy. Following negative ileo-colo-
noscopy inspection, routine histopathological assess-
ment of the terminal ileum has substantial costs and
no clinical impact on the diagnostic work-up of
CNBD, except for specific indications such as
immune-compromised patients, suspicion of intestinal
tuberculosis, human immunodeficiency virus infection
or graft-vs-host disease. By contrast, histopathology
based on multiple biopsies is crucial for the diagnostic
definition of microscopic colitis and of any visible
inflammatory lesion detected during ileo-colonoscopy
for CNBD.
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